MA-BRIGHTCOVE/SUNN-STRM
Brightcove (NASDAQ: BCOV), the world’s most trusted streaming technology company, today announced it has added Sunn Stream – a streaming service offering family-friendly movies, music and educational content – to its roster of media customers. Sunn Stream will rely on Brightcove’s two-time Emmy-award-winning platform to distribute its content to audiences nationwide.
Sunn Stream, currently in soft launch, is a streaming service that provides subscribers with personalized, family-friendly content, including movies, music, episodic shows, and educational videos on various topics. Using Brightcove’s reliable and scalable video technology, Sunn Stream will provide its audience with a seamless, curated, user-friendly experience across all devices.
“The streaming industry has clearly become more competitive, with providers striving to capture the attention and loyalty of more discerning audiences,” said Brightcove CEO Marc DeBevoise. “With this evolution, Sunn Stream has realized that it is essential to combine its unique content proposition targeted at a clearly-defined audience with the highest-quality video streaming and an intuitive, personalized user experience. Using our market-leading technology platform, Sunn Stream will be at the forefront of providing their customers with reliable, customized entertainment options, and will have access to best-in-class analytics to track performance.”
The popularity of independent media companies has continued to surge. As more consumers enter the fold, these entities increasingly require partners that can scale with them and ensure that customer experience remains a top priority. Sunn Stream tapped Brightcove’s industry-leading video-cloud streaming platform for its unique advantages, including unparalleled video quality, global scalability, unmatched customer support, and robust analytics.
“We’ve completely updated our Sunn Stream streaming service and app to make them easier to use so more customers can enjoy our films and shows,” said Sunn Stream Founder and President Garrett Z. Sutton. “Our curators will now handpick unexpected recommendations that our customers will love. And we’re more focused on creating an experience for the whole family that brings people together with laughter, tears, and thought-provoking moments.”
Sunn Stream joins a roster of media companies that rely on Brightcove to power their streaming capabilities, including FrightPix, The Academy of Motion Picture Arts and Sciences, Acun Medya, AMC Networks, BBC Studios, Canela Media, J.COM, MotoAmerica, REELZ, SBT TV, and SKY Mexico.
For more information, visit Brightcove.com.
About Sunn Stream
Sunn Stream is more than a streaming platform — it’s an Uncharted Entertainment and Educational Journey that takes users to bold, new worlds of cinema and television with family-friendly online content (movies, music and more) and a new Sunn Stream Film Festival (Coming Soon in 2025). As a modern-day storytelling campfire, it unites people through laughter, tears, and thought-provoking moments. This user-friendly platform delivers new narratives and experiences that appeal to multiple generations. Each month, Sunn Stream’s content curators handpick a collection of unexpected tales that ignite wonder, invite conversations and bridge hearts and minds. In addition to films and exclusive documentaries, this online platform offers quality educational content to fill voids left by public institutions such as financial education. Sunn Stream Members/ Subscribers will have unlimited access to new content that can ignite discussions with friends and family. Founded in 2022, Sunn Stream Founder/President, Bestselling Author and Entrepreneur Garrett Z. Sutton is dedicated to entertaining, educating and expanding horizons for users with new content that enhances lives. And Sunn Stream’s unique platform can be experienced online via SunnStream.com, Sunn Stream Productions App (iOS for iPads and iPhones, Apps for Android) and through Roku, Chromecast, and/or Apple TV devices. And when the credits roll, the journey is just beginning: https://sunnstream.com.
About Brightcove Inc.
Brightcove creates the world’s most reliable, scalable, and secure streaming technology solutions to build a greater connection between companies and their audiences, no matter where they are or on which devices they consume content. In more than 60 countries, Brightcove’s intelligent video platform enables businesses to sell to customers more effectively, media leaders to stream and monetize content more reliably, and every organization to communicate with team members more powerfully. With two Technology and Engineering Emmy® Awards for innovation, uptime that consistently leads the industry, and unmatched scalability, we continuously push the boundaries of what video can do. Follow Brightcove on LinkedIn, X, Facebook, Instagram, Threads, and YouTube. Visit Brightcove.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240716111027/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom